Skip to main content

Trial design: no pain, no gain

By 16 Dicembre 2019Maggio 12th, 2021No Comments

The 10th edition of the Melanoma Bridge certainly could not miss Omid Hamid. This year, the director of Immunotherapy and Translational Research at The Angeles Clinic and Research Institute in Los Angeles told us about the opportunity to rethink trial design in order to benefit melanoma patients.